Skip to main content
Zai Lab Limited logo

Zai Lab Limited — Investor Relations & Filings

Ticker · 9688 ISIN · KYG9887T1168 LEI · 549300P2UYQ9U5LY1T58 HKEX Manufacturing
Open in API
Filings indexed 388 across all filing types
Latest filing 2021-04-13 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 9688

About Zai Lab Limited

http://www.zailaboratory.com

Zai Lab Limited is an innovative, research-based, commercial-stage biopharmaceutical company dedicated to discovering, developing, and commercializing transformative therapies that address medical conditions with significant unmet needs. The company focuses its pipeline and development efforts across four core therapeutic areas: oncology, immunology, neuroscience, and infectious disease. Zai Lab employs a strategy of internal research and global partnerships to advance best-in-class and first-in-class medicines. A key commercial product is ZEJULA (niraparib), utilized as a maintenance treatment for ovarian cancer in markets including mainland China.

Recent filings

Filing Released Lang Actions
OVERSEAS REGULATORY ANNOUNCEMENT
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the U.S. Securities and Exchange Commission (SEC) by Zai Lab Limited. It reports an update on a clinical trial (the LUNAR trial) conducted by Zai Lab and its partner Novocure. The document includes a joint press release and details about the trial's interim analysis and recommendations by the independent data monitoring committee. The filing is a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, which is used to report unscheduled material events or corporate changes. The document is not a full annual or quarterly report, nor is it an earnings release or management discussion. It is a regulatory announcement of a material event, specifically a clinical trial update, filed as a Form 8-K. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-04-13 English
INSIDE INFORMATION ANNOUNCEMENT-THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION APPROVED THE NEW DRUG APPLICATION FOR QINLOCK FOR TREATMENT OF ADVANCED GASTROINTESTINAL STROMAL TUMORS
Regulatory Filings Classification · 95% confidence The document is an announcement made pursuant to the Listing Rules of the Hong Kong Stock Exchange and the Securities and Futures Ordinance. It announces the approval by the National Medical Products Administration (NMPA) of a new drug application (NDA) for QINLOCK for treatment of advanced gastrointestinal stromal tumors. The document is titled as an "INSIDE INFORMATION ANNOUNCEMENT" and contains no financial statements or detailed financial data. It is a regulatory announcement about a significant corporate event (drug approval) rather than a financial report or management discussion. The document length is 4426 characters, which is relatively short and consistent with an announcement rather than a full report. There is no indication that this is a report publication announcement or a certification. The content fits best under Regulatory Filings (RNS) as it is a regulatory announcement about a material event affecting the company.
2021-03-31 English
2020 ANNUAL REPORT
Annual Report Classification · 100% confidence The document is a comprehensive report from Zai Lab Limited covering the fiscal year ended December 31, 2020. It includes a Chairperson's statement, definitions, corporate information, financial highlights with detailed financial data, auditor's report mention, and references to Form 10-K. The presence of consolidated financial statements, auditor's report, and detailed financial and operational data indicates this is a full annual report. The document length is substantial (15,000 characters), and it contains actual financial statements and analysis, not just an announcement or summary. Therefore, it fits the definition of an Annual Report (10-K). FY 2020
2021-03-01 English
OVERSEAS REGULATORY ANNOUNCEMENT
Report Publication Announcement Classification · 95% confidence The document is an announcement made pursuant to a regulatory rule (Rule 13.10B) regarding the filing of an annual report on Form 10-K for the fiscal year ended December 31, 2020. The text states that the Form 10-K was filed on March 1, 2021, and is available on the SEC and company websites. The document itself does not contain the full annual report or financial data but merely announces the filing and availability of the report. The document length is short (1553 characters), consistent with an announcement rather than the full report. According to the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA) rather than the actual 10-K report.
2021-03-01 English
ANNOUNCEMENT OF THE 2020 FISCAL YEAR FINANCIAL RESULTS
Annual Report Classification · 95% confidence The document is an announcement titled 'ANNOUNCEMENT OF THE 2020 FISCAL YEAR FINANCIAL RESULTS' for Zai Lab Limited, covering audited results for the fiscal year ended December 31, 2020. It includes detailed financial results, corporate updates, product highlights, and anticipated milestones. The text contains substantive financial and operational data, not merely a notice or link to a report. It is not a short announcement or certification but a comprehensive disclosure of annual financial performance and business outlook. Therefore, it fits the definition of an Annual Report (10-K) or equivalent annual financial results announcement. Given the detailed nature and length (15,000 characters), it is classified as an Annual Report (10-K) type filing rather than a simple announcement or regulatory filing. FY 2020
2021-03-01 English
NOTICE OF BOARD ACTION AND DATE OF PUBLICATION OF FISCAL YEAR 2020 RESULTS ANNOUNCEMENT
Report Publication Announcement Classification · 95% confidence The document is a short announcement (1827 characters) from Zai Lab Limited regarding the board's planned approval and publication date of the fiscal year 2020 audited results. It states that the results announcement will be published on March 1, 2021, and mentions a subsequent earnings call. The document does not contain the actual financial results or detailed report but only informs about the timing and process of the results release. According to the 'Menu vs Meal' rule, such a brief notice about the upcoming report publication is classified as a Report Publication Announcement (RPA), not the Annual Report or Earnings Release itself.
2021-02-16 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.